Our study demonstrated that hepatic RORα, in cooperation with MED23, plays a role in inflammatory responses, acting as a positive regulator of CCL5 and CXCL10 in initiating the liver fibrosis, which suggests new molecular targets for clinical intervention in liver fibrosis. Here, MED23 is linked to Hepatic fibrosis.